DK3365436T3 - Fremgangsmåder til fremstilling af en primær celleprøve - Google Patents

Fremgangsmåder til fremstilling af en primær celleprøve Download PDF

Info

Publication number
DK3365436T3
DK3365436T3 DK16791191.6T DK16791191T DK3365436T3 DK 3365436 T3 DK3365436 T3 DK 3365436T3 DK 16791191 T DK16791191 T DK 16791191T DK 3365436 T3 DK3365436 T3 DK 3365436T3
Authority
DK
Denmark
Prior art keywords
preparing
methods
primary cell
cell sample
sample
Prior art date
Application number
DK16791191.6T
Other languages
Danish (da)
English (en)
Inventor
Lance Gavin Laing
Ben Rich
Abhijit Dandapat
Original Assignee
Celcuity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celcuity Inc filed Critical Celcuity Inc
Application granted granted Critical
Publication of DK3365436T3 publication Critical patent/DK3365436T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/48—Regulators of apoptosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/73—Hydrolases (EC 3.)
    • C12N2501/734—Proteases (EC 3.4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK16791191.6T 2015-10-20 2016-10-20 Fremgangsmåder til fremstilling af en primær celleprøve DK3365436T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562243765P 2015-10-20 2015-10-20
PCT/US2016/057923 WO2017070353A1 (en) 2015-10-20 2016-10-20 Methods of preparing a primary cell sample

Publications (1)

Publication Number Publication Date
DK3365436T3 true DK3365436T3 (da) 2021-10-11

Family

ID=57233884

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16791191.6T DK3365436T3 (da) 2015-10-20 2016-10-20 Fremgangsmåder til fremstilling af en primær celleprøve

Country Status (9)

Country Link
US (2) US11591573B2 (enExample)
EP (1) EP3365436B1 (enExample)
JP (2) JP7202613B2 (enExample)
KR (1) KR102757122B1 (enExample)
CN (1) CN108138146A (enExample)
AU (1) AU2016341938B2 (enExample)
CA (1) CA2999054A1 (enExample)
DK (1) DK3365436T3 (enExample)
WO (1) WO2017070353A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017070353A1 (en) 2015-10-20 2017-04-27 Celcuity Llc Methods of preparing a primary cell sample
CN108300688B (zh) * 2018-02-07 2021-02-02 上海赛立维生物科技有限公司 原代肝细胞分离和培养方法
CN109402051A (zh) * 2018-12-28 2019-03-01 青岛麦迪赛斯生物科技有限公司 一种人脐带间充质干细胞无血清培养基
CN109777736B (zh) * 2019-01-29 2022-03-25 美闺(长沙)医疗美容有限公司 一种活细胞分析设备及方法
CN109943520B (zh) * 2019-03-08 2023-06-23 中国人民解放军军事科学院军事医学研究院 汗腺细胞的分离和培养获得汗腺类器官的方法及其应用
EP4073516A1 (en) 2019-12-09 2022-10-19 Celcuity Inc. Methods of treating cancer patients with ras node or rtk targeted therapeutic agents
CN111733136B (zh) * 2020-06-29 2021-11-30 中山大学孙逸仙纪念医院 一种提高CD90posi细胞分离效率的方法
US20260135422A1 (en) 2021-10-27 2026-05-14 Sumitomo Bakelite Co., Ltd. Stator and structure

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG47996A1 (en) 1993-12-30 1998-04-17 Nitta Gelatin Kk Method for culturing animal cells under embedded conditions
US5858678A (en) 1994-08-02 1999-01-12 St. Louis University Apoptosis-regulating proteins
US8252591B2 (en) 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
US20090130064A1 (en) 2004-10-27 2009-05-21 Vera Rogiers Differentiation of stem cells and stabilization of phenotypical properties of primary cells
FR2894594B1 (fr) * 2005-12-12 2008-02-08 Univ Limoges Test predictif de reponse therapeutique du cancer du sein
EA201070521A1 (ru) * 2007-11-20 2011-02-28 Опито Юниверситер Де Женева Способы идентификации, очистки и обогащения незрелых или стволовых клеток-инициаторов злокачественного роста из опухолей и их применение
US9096827B2 (en) 2008-09-02 2015-08-04 Pluristem Ltd. Adherent cells from placenta tissue and use thereof in therapy
JP5774496B2 (ja) 2010-01-19 2015-09-09 株式会社ルネッサンス・エナジー・インベストメント 癌組織由来細胞塊または癌細胞凝集塊の培養方法、評価方法および保存方法
EP2566975A4 (en) 2010-05-03 2014-04-02 Microstem Inc SCREENING METHODS, COMPOSITIONS IDENTIFIED BY THIS METHOD, TOOLS USEFUL FOR THEIR IDENTIFICATION AND CELLULAR POPULATIONS THUS PRODUCED
TWI477599B (zh) 2011-01-28 2015-03-21 鴻海精密工業股份有限公司 培育基體
NO2764099T3 (enExample) * 2011-10-04 2018-04-21
US20130330761A1 (en) 2012-06-12 2013-12-12 Celcuity, LLC Whole cell assays and methods
US20140142000A1 (en) * 2012-10-25 2014-05-22 Academia Sinica Microfluidic array platform for simultaneous cell culture under oxygen tensions
CA3106271A1 (en) * 2013-01-25 2014-07-31 Xcell Biosciences, Inc. Methods, compositions, kits, and systems for selective enrichment of target cells
GB201303491D0 (en) * 2013-02-27 2013-04-10 Cancer Rec Tech Ltd Culture of leukemia initiating cells
WO2015089380A2 (en) * 2013-12-12 2015-06-18 Celcuity Llc Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent
WO2015156929A1 (en) * 2014-04-07 2015-10-15 The Trustees Of Columbia University In The City Of New York Method for culture of human bladder cell lines and organoids and uses thereof
WO2017070353A1 (en) 2015-10-20 2017-04-27 Celcuity Llc Methods of preparing a primary cell sample

Also Published As

Publication number Publication date
EP3365436B1 (en) 2021-09-08
JP2018531021A (ja) 2018-10-25
KR20180057653A (ko) 2018-05-30
AU2016341938B2 (en) 2022-12-01
WO2017070353A1 (en) 2017-04-27
US20180230434A1 (en) 2018-08-16
JP7202613B2 (ja) 2023-01-12
EP3365436A1 (en) 2018-08-29
CN108138146A (zh) 2018-06-08
US12215356B2 (en) 2025-02-04
KR102757122B1 (ko) 2025-01-21
CA2999054A1 (en) 2017-04-27
JP2021175415A (ja) 2021-11-04
HK1252635A1 (zh) 2019-05-31
US20230235293A1 (en) 2023-07-27
US11591573B2 (en) 2023-02-28
AU2016341938A1 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
DK3374748T3 (da) Fremgangsmåde til udarbejdelse af et prøveforsøg
DK4008782T3 (da) Fremgangsmåder til tilvejebringelse af enkeltstrenget rna
DK3519094T3 (da) System til forberedelse af en prøve
DK3122444T3 (da) Fremgangsmåde til fremstilling af membraner
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
DK3186376T3 (da) Fremgangsmåder til forbedring af cas9-medieret manipulationseffektivitet
DK3444334T3 (da) Fremgangsmåde til inducering af CD8+ T-celler
DK3940352T3 (da) Fremgangsmåde til diagnosticering af vægte
DK3110988T3 (da) Metoder til behandling af lithiumholdige materialer
DK3789042T3 (da) Fremgangsmåde til fremstilling af anti-her3-antistof-lægemiddelkonjugat
DK3529611T3 (da) Fremgangsmåder til screening af b-cellelymfocytter
DK3285784T3 (da) Fremgangsmåde til fremstilling af en prøve af fækal mikrobiota
DK3247201T3 (da) Fremgangsmåder til opgradering af brugt biomassemateriale
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3152176T5 (da) Fremgangsmåde til fremstillingen af en cementforbindelse
DK3344805T3 (da) Fremgangsmåde til udvælgelse af aptamerer til ubundne mål
DK3376923T3 (da) Fremgangsmåde til tilberedning af en drik
DK3529233T3 (da) Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider
DK3314010T3 (da) Fremgangsmåde til detektering af kromosomaberrationer
DK3195345T3 (da) Fremgangsmåde til karakterisering af en prøve ved billeddannelse ved massespektrometri
DK3393660T3 (da) Fremgangsmåde til fremstilling af en tæt beholder
DK3367910T3 (da) Fremgangsmåde til anvendelse af en sondeafdækning
DK3304037T3 (da) Fremgangsmåde til opsamling af cellekolonier
DK3274143T3 (da) Fremgangsmåde til fremstilling af lignocellulosematerialer
DK3384045T3 (da) Fremgangsmåde til bestemmelse af celleklonalitet